A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): a feasibility trial

A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): a feasibility trial

<br><strong>Background: </strong>Trials of lowering blood pressure in patients with acute ischaemic stroke not undergoing thrombolysis have not demonstrated improved outcomes with intervention. Rather than absolute levels, it may be that blood pressure variability is important. How...

書誌詳細
主要な著者:	Davison, WJ, Appiah, K, Robinson, TG, McGurgan, IJ, Rothwell, PM, Potter, JF
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2020

類似資料

Randomised controlled trial of a calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduce blood pressure variability following ischaemic stroke (CAARBS): a protocol for a feasibility study
著者:: Robinson, T, 等
出版事項: (2019)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
著者:: Myla E. Moretti, 等
出版事項: (2012-01-01)

Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy
著者:: Letian Zhou, 等
出版事項: (2014-03-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
著者:: Hyun Woo Lee, 等
出版事項: (2021-03-01)

Monitoring and controlling blood pressure after stroke and transient ischaemic attack
著者:: McGurgan, I
出版事項: (2021)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
著者:: Hye-Ran Jun, 等
出版事項: (2021-01-01)

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
著者:: Jin Sun Choi, 等
出版事項: (2023-11-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
著者:: S Bhuvaneshwari, 等
出版事項: (2018-07-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
著者:: Yudi Her Oktaviono, 等
出版事項: (2020-04-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
著者:: Ha Yeon Kim, 等
出版事項: (2014-12-01)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
著者:: Zhang C, 等
出版事項: (2021-02-01)

Is there any difference between angiotensin converting enzyme inhibitors and angiotensin receptor blockers for heart failure?
著者:: Carmen Rain, 等
出版事項: (2015-07-01)

Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury
著者:: P R Shah, 等
出版事項: (2011-01-01)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
著者:: Martin C.S. Wong, 等
出版事項: (2020-10-01)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
著者:: Éva Larouche‐Lebel, 等
出版事項: (2021-01-01)

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
著者:: Terry Huh, 等
出版事項: (2021-01-01)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
著者:: Marco Rossato, 等
出版事項: (2020-07-01)

Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
著者:: Wissam Mekary, 等
出版事項: (2023-09-01)

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19
著者:: Michael Pan, 等
出版事項: (2021-12-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
著者:: James A. Ker
出版事項: (2015-05-01)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality of Coronary Artery Bypass Grafting
著者:: Ahmad Sharafi, 等
出版事項: (2015-10-01)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
著者:: Nitesh Gupta, 等
出版事項: (2020-01-01)

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria
著者:: Feng-Yi Hsu, 等
出版事項: (2017-06-01)

Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
著者:: Semaan G. Kosseifi, 等
出版事項: (2009-12-01)

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
著者:: Azadeh Khalili, 等
出版事項: (2021-07-01)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
著者:: Valentina Carubelli, 等
出版事項: (2021-06-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
著者:: Tao Liu, 等
出版事項: (2023-01-01)

Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on the In-Hospital Mortality of COVID-19 Patients
著者:: Mohsen Gholinataj Jelodar, 等
出版事項: (2024-06-01)

Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy
著者:: Shiori Iwane, 等
出版事項: (2024-01-01)

Perioperative management of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of perioperative medicine practitioners
著者:: Sophie L.M. Walker, 等
出版事項: (2018-06-01)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction.
著者:: Chih-Wei Chen, 等
出版事項: (2023-01-01)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
著者:: Chih-Wei Chen, 等
出版事項: (2023-01-01)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
著者:: Marie Douillard, MD, 等
出版事項: (2023-08-01)

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
著者:: Seyed Ali Sadjadi, 等
出版事項: (2009-07-01)

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies
著者:: Kayeong Shin, 等
出版事項: (2022-10-01)

Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
著者:: Huang Shiou-Huei, 等
出版事項: (2012-05-01)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
著者:: Bin Tu, 等
出版事項: (2021-11-01)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
著者:: Maki Komiyama, 等
出版事項: (2020-07-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
著者:: G. Savarese, 等
出版事項: (2015-09-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
著者:: E. V. Rebrova, 等
出版事項: (2024-01-01)